Page last updated: 2024-08-23

epirubicin and Lupus Erythematosus, Cutaneous, Subacute

epirubicin has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagot, M; Cosnes, A; Duong, TA; Gantzer, A; Ortonne, N; Regnier, S; Wolkenstein, P1

Reviews

1 review(s) available for epirubicin and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
[Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
    Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:5

    Topics: Adenocarcinoma; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bevacizumab; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Mastectomy; Middle Aged; Paclitaxel; Paraneoplastic Syndromes; Ribonucleoproteins; Salvage Therapy; Tamoxifen; Taxoids; Trastuzumab

2011